A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy-Reference-Cited by-同舟云学术

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

Published:2021-07 Issue:1 Volume:100 Page:215-224
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Wheeler David C.,Toto Robert D.,Stefánsson Bergur V.,Jongs Niels,Chertow Glenn M.,Greene Tom,Hou Fan Fan,McMurray John J.V.,Pecoits-Filho Roberto,Correa-Rotter Ricardo,Rossing Peter,Sjöström C. David,Umanath Kausik,Langkilde Anna Maria,Heerspink Hiddo J.L.

Funder

AstraZeneca PLC

Publisher

Elsevier BV

Subject

Nephrology

Reference34 articles.

1. IgA nephropathy;Wyatt;N Engl J Med,2013

2. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference;Floege;Kidney Int,2019

3. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China;Lv;Nephrology,2008

4. New strategies and perspectives on managing IgA nephropathy;Selvaskandan;Clin Exp Nephrol,2019

5. ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials;Cheng;Int J Clin Pract,2009

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: IgA nephropathy: a nephrologist’s challenge in 2023;Frontiers in Nephrology;2024-09-11

2. Variants in tubule epithelial regulatory elements mediate most heritable differences in human kidney function;Nature Genetics;2024-09-10

3. The pathogenesis of IgA nephropathy and implications for treatment;Nature Reviews Nephrology;2024-09-04

4. Therapy of IgA nephropathy: time for a paradigm change;Frontiers in Medicine;2024-08-15

5. Sodium glucose co-transporter 2 inhibitors in the treatment of glomerular diseases: a CKJ controversy;Clinical Kidney Journal;2024-08-12